Annual CFO
-$79.00 M
+$392.00 K+0.49%
December 31, 2023
Summary
- As of February 8, 2025, ALGS annual cash flow from operations is -$79.00 million, with the most recent change of +$392.00 thousand (+0.49%) on December 31, 2023.
- During the last 3 years, ALGS annual CFO has fallen by -$4.73 million (-6.37%).
- ALGS annual CFO is now -68.92% below its all-time high of -$46.77 million, reached on December 31, 2019.
Performance
ALGS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$20.10 M
-$608.00 K-3.12%
September 30, 2024
Summary
- As of February 8, 2025, ALGS quarterly cash flow from operations is -$20.10 million, with the most recent change of -$608.00 thousand (-3.12%) on September 30, 2024.
- Over the past year, ALGS quarterly CFO has increased by +$2.56 million (+11.29%).
- ALGS quarterly CFO is now -47.63% below its all-time high of -$13.62 million, reached on June 30, 2023.
Performance
ALGS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$85.00 M
+$235.00 K+0.28%
September 30, 2024
Summary
- As of February 8, 2025, ALGS TTM cash flow from operations is -$85.00 million, with the most recent change of +$235.00 thousand (+0.28%) on September 30, 2024.
- Over the past year, ALGS TTM CFO has dropped by -$6.00 million (-7.60%).
- ALGS TTM CFO is now -318.32% below its all-time high of -$20.32 million, reached on March 31, 2020.
Performance
ALGS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ALGS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.5% | +11.3% | -7.6% |
| 3 y3 years | -6.4% | +10.2% | -4.5% |
| 5 y5 years | - | +10.2% | -4.5% |
ALGS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.7% | -47.6% | +46.4% | -21.6% | +26.5% |
| 5 y | 5-year | -68.9% | +31.7% | -47.6% | +46.4% | -318.3% | +26.5% |
| alltime | all time | -68.9% | +31.7% | -47.6% | +46.4% | -318.3% | +26.5% |
Aligos Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.10 M(+3.1%) | -$85.00 M(-0.3%) |
| Jun 2024 | - | -$19.49 M(-14.3%) | -$85.23 M(+7.4%) |
| Mar 2024 | - | -$22.75 M(+0.4%) | -$79.36 M(+0.5%) |
| Dec 2023 | -$79.00 M(-0.5%) | -$22.66 M(+11.4%) | -$79.00 M(+8.0%) |
| Sep 2023 | - | -$20.34 M(+49.4%) | -$73.12 M(+4.6%) |
| Jun 2023 | - | -$13.62 M(-39.2%) | -$69.92 M(-14.0%) |
| Mar 2023 | - | -$22.39 M(+33.4%) | -$81.34 M(+2.5%) |
| Dec 2022 | -$79.39 M | -$16.78 M(-2.1%) | -$79.39 M(-20.7%) |
| Sep 2022 | - | -$17.14 M(-31.5%) | -$100.09 M(-7.6%) |
| Jun 2022 | - | -$25.04 M(+22.5%) | -$108.32 M(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$20.43 M(-45.5%) | -$106.30 M(-8.1%) |
| Dec 2021 | -$115.66 M(+55.7%) | -$37.48 M(+47.7%) | -$115.66 M(+18.2%) |
| Sep 2021 | - | -$25.37 M(+10.2%) | -$97.87 M(+9.9%) |
| Jun 2021 | - | -$23.02 M(-22.7%) | -$89.06 M(+6.4%) |
| Mar 2021 | - | -$29.80 M(+51.4%) | -$83.74 M(+12.8%) |
| Dec 2020 | -$74.26 M(+58.8%) | -$19.68 M(+18.8%) | -$74.26 M(+36.1%) |
| Sep 2020 | - | -$16.57 M(-6.4%) | -$54.58 M(+43.6%) |
| Jun 2020 | - | -$17.69 M(-12.9%) | -$38.01 M(+87.1%) |
| Mar 2020 | - | -$20.32 M | -$20.32 M |
| Dec 2019 | -$46.77 M | - | - |
FAQ
- What is Aligos Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Aligos Therapeutics?
- What is Aligos Therapeutics annual CFO year-on-year change?
- What is Aligos Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly CFO year-on-year change?
- What is Aligos Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Aligos Therapeutics?
- What is Aligos Therapeutics TTM CFO year-on-year change?
What is Aligos Therapeutics annual cash flow from operations?
The current annual CFO of ALGS is -$79.00 M
What is the all time high annual CFO for Aligos Therapeutics?
Aligos Therapeutics all-time high annual cash flow from operations is -$46.77 M
What is Aligos Therapeutics annual CFO year-on-year change?
Over the past year, ALGS annual cash flow from operations has changed by +$392.00 K (+0.49%)
What is Aligos Therapeutics quarterly cash flow from operations?
The current quarterly CFO of ALGS is -$20.10 M
What is the all time high quarterly CFO for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly cash flow from operations is -$13.62 M
What is Aligos Therapeutics quarterly CFO year-on-year change?
Over the past year, ALGS quarterly cash flow from operations has changed by +$2.56 M (+11.29%)
What is Aligos Therapeutics TTM cash flow from operations?
The current TTM CFO of ALGS is -$85.00 M
What is the all time high TTM CFO for Aligos Therapeutics?
Aligos Therapeutics all-time high TTM cash flow from operations is -$20.32 M
What is Aligos Therapeutics TTM CFO year-on-year change?
Over the past year, ALGS TTM cash flow from operations has changed by -$6.00 M (-7.60%)